Rapport Therapeutics, Inc. · NASDAQ:RAPP

Cormorant Asset Management, LP reported a 6.70% stake in Rapport Therapeutics, Inc. (Schedule 13G/A)

Event Sep 30, 2025 · Filed Nov 14, 2025

Cormorant Asset Management, LP reported a 6.70% stake in Rapport Therapeutics, Inc., 3,192,521 shares, as a passive investor on Sep 30, 2025. Filed Nov 14, 2025 (Schedule 13G/A).

Stake
6.70%
Shares
3,192,521
Intent
Passive
What changed
Stake changed
Filed together
2 holders

The filing in full

HolderStakeShares
Cormorant Asset Management, LP6.70%3,192,521
Bihua Chen6.70%3,192,521

Source

View original at SEC

Related